Boai NKY Medical Holdings Ltd.

XSEC:300109 Stock Report

Market Cap: CN¥8.1b

Boai NKY Medical Holdings Past Earnings Performance

Past criteria checks 3/6

Boai NKY Medical Holdings has been growing earnings at an average annual rate of 37.2%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 13% per year. Boai NKY Medical Holdings's return on equity is 11.4%, and it has net margins of 26.8%.

Key information

37.2%

Earnings growth rate

36.1%

EPS growth rate

Chemicals Industry Growth12.1%
Revenue growth rate13.0%
Return on equity11.4%
Net Margin26.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Boai NKY Medical Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

XSEC:300109 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,48839923066
30 Jun 241,53944423576
31 Mar 241,61549424766
31 Dec 231,58349324564
30 Sep 231,56641924261
30 Jun 231,58640824866
31 Mar 231,53837923066
01 Jan 231,48629123466
30 Sep 221,48138523962
30 Jun 221,36227025760
31 Mar 221,24617727065
01 Jan 221,22020726576
30 Sep 211,1586828072
30 Jun 211,0707724971
31 Mar 211,0439521675
31 Dec 209794522070
30 Sep 209509620475
30 Jun 2097311318770
31 Mar 2098710619858
31 Dec 1992412317549
30 Sep 1987911315949
30 Jun 197859614348
31 Mar 197169413751
31 Dec 186989012551
30 Sep 186219810445
30 Jun 18567958353
31 Mar 18522937741
31 Dec 17489938333
30 Sep 17455917919
30 Jun 1742989940
31 Mar 1741484850
31 Dec 1640180780
30 Sep 1638182680
30 Jun 1636674680
31 Mar 1632064570
31 Dec 1529157530
30 Sep 1526346460
30 Jun 1525542400
31 Mar 1525638400
31 Dec 1425330380
30 Sep 1424327350
30 Jun 1422323340
31 Mar 1421721330
31 Dec 1320920320

Quality Earnings: 300109 has high quality earnings.

Growing Profit Margin: 300109's current net profit margins (26.8%) are higher than last year (26.7%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 300109's earnings have grown significantly by 37.2% per year over the past 5 years.

Accelerating Growth: 300109's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 300109 had negative earnings growth (-4.7%) over the past year, making it difficult to compare to the Chemicals industry average (-4.7%).

Return on Equity

High ROE: 300109's Return on Equity (11.4%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 16:33
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Boai NKY Medical Holdings Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jun LiuChangjiang Securities Co. LTD.
Zheng ZhouChina Merchants Securities Co. Ltd.
Zhenghua ZhangFounder Securities Co., Ltd.